Rising to the Challenges of Clinical Trial Improvement in Parkinson’s Disease

Author:

Mathur Soania12,DeWitte Steve23,Robledo Israel23,Isaacs Tom24,Stamford Jon24

Affiliation:

1. Designing a Cure Inc, Toronto, Canada

2. Parkinson’s Movement, London, UK

3. Parkinson’s Action Network, Washington, DC, USA

4. The Cure Parkinson’s Trust, London, UK

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Clinical Neurology

Reference12 articles.

1. Corr P Williams D 2009 The pathway from idea to regulatory approval: Examples for drug development Conflict of Interest in Medical Research, Education, and Practice National Academies (US) Washington

2. DiMassi JA 2014 Cost to develop and win marketing approval for a new drug is $2.6 billion. PR Tufts CSDD 2014 Cost Study. Tufts Center for the Study of Drug Development http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014_cost_study

3. Estimating the cost of new drug development: Is it really $802 million?;Adams;Health Aff (Millwood),2006

4. Roy ASA 2012 Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials. Rep. no. 5. Manhattan Institute for Policy Research, http://www.manhattan-institute.org/html/fda_05.htm

5. Getz K 2009 Current investigator landscape poses growing challenges for sponsors, Impact Report Tufts Center for the Study of Drug Development 11 1 (2009)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3